NOVAST

301569
17.244.17% ( -0.75 )
Delay Closed: Nov 16, 15:00:00

Profile

About

NOVAST
NOVAST
301569.SZ

NOVAST Laboratories, Limited develops, manufactures, and sells prescription drug formulations. The company produces controlled-release formulations, including extended-release and sustained-release tablets and capsules, as well as low-dose drug formulations. Its products include Metoprolol Succinate Extended-Release Tablets, Nifedipine Extended-Release Tablets, Diltiazem Hydrochloride Extended-Release Capsules, Metformin Hydrochloride Sustained-Release Tablets, Levonorgestrel Tablets, Memantine Hydrochloride Extended-Release Capsules, Quetiapine Fumarate Sustained-Release Tablets, and Tolterodine tablets for urinary frequency and urgency. The company also develops a digestive-system extended-release tablet designated DG-062.

Profile

Company Name
NOVAST Laboratories, Limited
Market
SZSE
Founded
Industry
--
Fiscal Year End
--

Related Securities

Industry

Management